241 related articles for article (PubMed ID: 15900289)
1. Renal effects of the cyclooxygenase-inhibiting nitric oxide donator AZD3582 compared with rofecoxib and naproxen during normal and low sodium intake.
Huledal G; Jonzon B; Malmenäs M; Hedman A; Andersson LI; Odlind B; Brater DC
Clin Pharmacol Ther; 2005 May; 77(5):437-50. PubMed ID: 15900289
[TBL] [Abstract][Full Text] [Related]
2. Analgesic efficacy of the cyclooxygenase-inhibiting nitric oxide donor AZD3582 in postoperative dental pain: Comparison with naproxen and rofecoxib in two randomized, double-blind, placebo-controlled studies.
Michael Hill C; Sindet-Pederson S; Seymour RA; Hawkesford JE; Coulthard P; Lamey PJ; Gerry Cowan C; Wickens M; Jeppsson L; Dean AD; Svensson O
Clin Ther; 2006 Sep; 28(9):1279-95. PubMed ID: 17062301
[TBL] [Abstract][Full Text] [Related]
3. Pre-clinical pharmacokinetics of the cyclooxygenase-inhibiting nitric oxide donor (CINOD) AZD3582.
Fagerholm U; Breuer O; Swedmark S; Hoogstraate J
J Pharm Pharmacol; 2005 May; 57(5):587-97. PubMed ID: 15901348
[TBL] [Abstract][Full Text] [Related]
4. Comparison of rofecoxib, celecoxib, and naproxen on renal function in elderly subjects receiving a normal-salt diet.
Schwartz JI; Vandormael K; Malice MP; Kalyani RN; Lasseter KC; Holmes GB; Gertz BJ; Gottesdiener KM; Laurenzi M; Redfern KJ; Brune K
Clin Pharmacol Ther; 2002 Jul; 72(1):50-61. PubMed ID: 12152004
[TBL] [Abstract][Full Text] [Related]
5. Clinical pharmacokinetics of the cyclooxygenase inhibiting nitric oxide donator (CINOD) AZD3582.
Fagerholm U; Björnsson MA
J Pharm Pharmacol; 2005 Dec; 57(12):1539-54. PubMed ID: 16354398
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the COX-inhibiting nitric oxide donator AZD3582 and rofecoxib in treating the signs and symptoms of Osteoarthritis of the knee.
Schnitzer TJ; Kivitz AJ; Lipetz RS; Sanders N; Hee A
Arthritis Rheum; 2005 Dec; 53(6):827-37. PubMed ID: 16342089
[TBL] [Abstract][Full Text] [Related]
7. Dose-effect comparisons of the CINOD AZD3582 and naproxen on upper gastrointestinal tract mucosal injury in healthy subjects.
Wilder-Smith CH; Jonzon B; Fornstedt-Wallin B; Hedman A; Karlsson P
Scand J Gastroenterol; 2006 Mar; 41(3):264-73. PubMed ID: 16497612
[TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal safety of AZD3582, a cyclooxygenase inhibiting nitric oxide donator: proof of concept study in humans.
Hawkey CJ; Jones JI; Atherton CT; Skelly MM; Bebb JR; Fagerholm U; Jonzon B; Karlsson P; Bjarnason IT
Gut; 2003 Nov; 52(11):1537-42. PubMed ID: 14570719
[TBL] [Abstract][Full Text] [Related]
9. A randomised, placebo controlled, comparative trial of the gastrointestinal safety and efficacy of AZD3582 versus naproxen in osteoarthritis.
Lohmander LS; McKeith D; Svensson O; Malmenäs M; Bolin L; Kalla A; Genti G; Szechinski J; Ramos-Remus C;
Ann Rheum Dis; 2005 Mar; 64(3):449-56. PubMed ID: 15345500
[TBL] [Abstract][Full Text] [Related]
10. Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects.
Rossat J; Maillard M; Nussberger J; Brunner HR; Burnier M
Clin Pharmacol Ther; 1999 Jul; 66(1):76-84. PubMed ID: 10430112
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the cyclooxygenase inhibitor-NO donors (CINOD), NMI-1182 and AZD3582, using in vitro biochemical and pharmacological methods.
Young DV; Cochran ED; Dhawan V; Earl RA; Ellis JL; Garvey DS; Janero DR; Khanapure SP; Letts LG; Melim TL; Murty MG; Shumway MJ; Wey SJ; Zemtseva IS; Selig WM
Biochem Pharmacol; 2005 Nov; 70(9):1343-51. PubMed ID: 16168964
[TBL] [Abstract][Full Text] [Related]
12. Effect of rofecoxib on the glomerular filtration rate, proteinuria and the renin-angiotensin-aldosterone system in elderly subjects with chronic renal impairment.
Horackova M; Schück O; Komers R; Charvat J; Teplan V; Kvapil M
Int J Clin Pharmacol Ther; 2005 Sep; 43(9):413-9. PubMed ID: 16163893
[TBL] [Abstract][Full Text] [Related]
13. Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids.
Catella-Lawson F; McAdam B; Morrison BW; Kapoor S; Kujubu D; Antes L; Lasseter KC; Quan H; Gertz BJ; FitzGerald GA
J Pharmacol Exp Ther; 1999 May; 289(2):735-41. PubMed ID: 10215647
[TBL] [Abstract][Full Text] [Related]
14. Direct gas measurements indicate that the novel cyclooxygenase inhibitor AZD3582 is an effective nitric oxide donor in vivo.
Adding LC; Agvald P; Andersson LI; Jonzon B; Hoogstraate J; Gustafsson LE
Br J Pharmacol; 2005 Jul; 145(5):679-87. PubMed ID: 15852032
[TBL] [Abstract][Full Text] [Related]
15. Effects of the cyclooxygenase inhibiting nitric oxide donator naproxcinod versus naproxen on systemic blood pressure in patients with osteoarthritis.
White WB; Schnitzer TJ; Fleming R; Duquesroix B; Beekman M
Am J Cardiol; 2009 Sep; 104(6):840-5. PubMed ID: 19733721
[TBL] [Abstract][Full Text] [Related]
16. Efficacy, safety, and tolerability of the cyclooxygenase-inhibiting nitric oxide donator naproxcinod in treating osteoarthritis of the hip or knee.
Karlsson J; Pivodic A; Aguirre D; Schnitzer TJ
J Rheumatol; 2009 Jun; 36(6):1290-7. PubMed ID: 19411388
[TBL] [Abstract][Full Text] [Related]
17. Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet. A randomized, controlled trial.
Swan SK; Rudy DW; Lasseter KC; Ryan CF; Buechel KL; Lambrecht LJ; Pinto MB; Dilzer SC; Obrda O; Sundblad KJ; Gumbs CP; Ebel DL; Quan H; Larson PJ; Schwartz JI; Musliner TA; Gertz BJ; Brater DC; Yao SL
Ann Intern Med; 2000 Jul; 133(1):1-9. PubMed ID: 10877734
[TBL] [Abstract][Full Text] [Related]
18. Effects of celecoxib and naproxen on renal function in nonazotemic patients with cirrhosis and ascites.
Clària J; Kent JD; López-Parra M; Escolar G; Ruiz-Del-Arbol L; Ginès P; Jiménez W; Vucelic B; Arroyo V
Hepatology; 2005 Mar; 41(3):579-87. PubMed ID: 15723448
[TBL] [Abstract][Full Text] [Related]
19. Celecoxib in the treatment of primary dysmenorrhea: results from two randomized, double-blind, active- and placebo-controlled, crossover studies.
Daniels S; Robbins J; West CR; Nemeth MA
Clin Ther; 2009 Jun; 31(6):1192-208. PubMed ID: 19695387
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of single-dose and multidose rofecoxib in the treatment of post-orthopedic surgery pain.
Reicin A; Brown J; Jove M; deAndrade JR; Bourne M; Krupa D; Walters D; Seidenberg B
Am J Orthop (Belle Mead NJ); 2001 Jan; 30(1):40-8. PubMed ID: 11198829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
